knowledge -WSS

knowledge

author：knowledge 2025-10-01 22:17:05 - browse：74

A person walks past the Palantir sign. -- health tech coverage from STAT — FABRICE COFFRINI/AFP via Getty Images

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.

Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools.

For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Juul spent big to court Black leaders to promote its e

entertainment

WSS

Mayo Clinic plans $5B tech

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

FDA investigates CAR

Disappointing trial forces Pfizer to pivot on obesity medicine plans

ReNAgade cuts staff seven months after raising $300 million

Fetal surgery at risk from Dobbs and new abortion restrictions

focus

knowledge

focus

Affirmative action in medical school literally saved lives

J&J to emphasize cancer drugs, stop much of its vaccine research

In Memoriam: Notable people who died in 2023

Biden administration opens offers in Medicare drug price negotiations

The high cost of giving birth even with insurance

Some dementia cases could be undiagnosed liver disease

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA drug safety: Singulair case shows systemic surveillance flaws

Walensky prepares to leave CDC — and Congress — behind

Takeda, Janssen join wearable maker to measure scratching

hotspot

How to pay for weight loss drugs and save Medicare

Vertex non

UnitedHealth’s Optum accused of antitrust violations in California

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Vertex non

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

explore

entertainment

leisure time

focus